Legence COO granted new stock and options

Legence Corp. Chief Operating Officer Stephen Dale Hansen received new equity compensation.

Rhea-AI Filing Summary

Legence Corp. Chief Operating Officer Stephen Dale Hansen received new equity compensation. He was granted 15,343 employee stock options with an exercise price of $50.90 per share and 8,298 Restricted Stock Units, both vesting in three equal annual installments, generally contingent on continued employment.

Following the grant, Hansen directly holds 25,262 shares of Class A common stock and 15,343 options, aligning his compensation more closely with the company’s future share performance.

Insider Trade Summary

Grant/Award: 23,641 shares

Grant/Award 2 txns

Insider Hansen Stephen Dale

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Options	15,343	$0.00	$0.00
Grant/Award	Class A Common Stock	8,298	$0.00	$0.00

Holdings After Transaction: Employee Stock Options — 15,343 contracts (Direct); Class A Common Stock — 25,262 shares (Direct)

Footnotes (2)

1. F1. The reported securities represent an award of Restricted Stock Units, which each entitle the reporting person to receive, at vesting, one share of Legence Corp.'s Class A common stock, par value $0.01 per share. The Restricted Stock Units vest in three substantially equal installments on each of the first, second and third anniversaries of the date of the award, subject generally to continued employment through the applicable vesting date.
2. F2. The options will vest in three substantially equal installments on each of the first, second and third anniversaries of the date of the award, subject generally to continued employment through the applicable vesting date. The options expire on the tenth anniversary of the date of the award.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Legence Corp. (LGN) report for Stephen Dale Hansen?

Legence reported that Chief Operating Officer Stephen Dale Hansen received equity awards, not open-market trades. He was granted 15,343 employee stock options and 8,298 Restricted Stock Units as compensation, increasing his direct ownership and aligning incentives with future Class A common stock performance.

How many stock options and RSUs did the Legence (LGN) COO receive?

Hansen received 15,343 employee stock options and 8,298 Restricted Stock Units. Each RSU entitles him to one share of Class A common stock at vesting, while the options allow future share purchases at a fixed exercise price, subject to the vesting schedule and continued employment conditions.

What is the vesting schedule for the new Legence (LGN) COO equity awards?

Both the Restricted Stock Units and the stock options vest in three substantially equal installments on the first, second, and third anniversaries of the award date. Vesting generally requires that Stephen Dale Hansen remain employed through each applicable anniversary to receive the corresponding portion of the awards.

What is the exercise price and expiration for the Legence (LGN) COO stock options?

The 15,343 employee stock options granted to Hansen carry an exercise price of $50.90 per share. These options vest over three years and expire on the tenth anniversary of the award date, providing a long-term incentive tied to future Class A common stock value.

How many Legence (LGN) Class A shares does the COO hold after these grants?

After the equity awards, Hansen directly holds 25,262 shares of Class A common stock. He also holds 15,343 employee stock options from this grant, which may be exercised in the future once vested, subject to the specified vesting schedule and expiration terms disclosed in the filing.

Were the Legence (LGN) COO transactions open-market purchases or compensation grants?

The reported transactions are compensation-related grants, not market purchases. Both entries carry transaction code “A,” indicating awards or other acquisitions. They represent a grant of stock options and Restricted Stock Units, issued at no cash cost per share on the grant date to the executive.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 05:37 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hansen Stephen Dale

(Last) (First) (Middle)

C/O LEGENCE CORP.

1601 LAS PLUMAS AVENUE

(Street)

SAN JOSE CALIFORNIA 95133

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Legence Corp. [ LGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock(1)	03/16/2026		A		8,298	A	$0	25,262	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options	$50.9	03/16/2026		A		15,343		(2)	(2)	Class A Common Stock	15,343	$0	15,343	D

Explanation of Responses:

1. The reported securities represent an award of Restricted Stock Units, which each entitle the reporting person to receive, at vesting, one share of Legence Corp.'s Class A common stock, par value $0.01 per share. The Restricted Stock Units vest in three substantially equal installments on each of the first, second and third anniversaries of the date of the award, subject generally to continued employment through the applicable vesting date.

2. The options will vest in three substantially equal installments on each of the first, second and third anniversaries of the date of the award, subject generally to continued employment through the applicable vesting date. The options expire on the tenth anniversary of the date of the award.

	/s/ Bryce Seki, as attorney-in-fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)